Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Macular Damage in Early Glaucoma and Progression
A completed clinical trial investigating macular damage and progression in patients with glaucoma.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
A completed clinical trial evaluating hybrid deep learning algorithms to detect eye diseases from fundus images. The study targeted conditio…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial [Phase 3]
NAMinG is a phase III, randomized, placebo-controlled trial evaluating nicotinamide for open-angle glaucoma, with recruitment ongoing across…
-
CLINICAL_TRIALS other · 2024-05-08Clinical Trial Update: Effects of Green Tea Consumption on Primary Glaucoma [NA]
A clinical trial sponsored by Universiti Sains Malaysia is evaluating the effects of green tea consumption on primary glaucoma and is curren…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) [NA]
The Dijon 3C Montrachet Cohort observational study examining signs of ocular degeneration in age-related macular degeneration and glaucoma h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer
The study is evaluating objective perimetry with a chromatic multifocal pupillometer and is currently recruiting at Sheba Medical Center for…
-
FDA approval · 2024-04-05FDA Approved: TAFLUPROST — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved Tafluprost as a generic product under an Original Application (ANDA) to Ingenus Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Rocklatan® Evaluation [Phase 4]
Phase 4 trial update for Rocklatan evaluated in glaucoma has completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops. [Phase 4]
Phase 4 trial assessing 20% autologous serum drops for corneal epitheliopathy associated with antihypertensive glaucoma drops; not yet recru…
-
FDA approval · 2024-02-20FDA Approved: DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE — Supplemental Application (Indoco Remedies Limited)
FDA approved a supplemental application for a dorzolamide hydrochloride-timolol maleate eye drop manufactured by Indoco Remedies Limited.
-
FDA approval · 2024-02-20FDA Approved: DORZOLAMIDE AND TIMOLOL — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for dorzolamide hydrochloride and timolol maleate ophthalmic solution from Leading Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma [NA]
A completed clinical trial investigating transorbital alternating current stimulation for glaucoma; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. [Phase 1, Phase 2]
Clinical trial update reports safety assessment of T4090 eye drops in patients with ocular hypertension or glaucoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: The Effect of Brimonidine [Phase 4]
Phase 4 clinical trial update on brimonidine for intraocular pressure with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery [Phase 4]
A Phase 4 prospective study assessing safety and efficacy of DEXTENZA following concomitant MIGS and cataract surgery was terminated with re…
-
FDA label_change · 2024-01-25FDA Approved: ACETAZOLAMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for acetazolamide by Hikma Pharmaceuticals USA Inc., resulting in labeling and/or manufacturing chan…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure [Phase 2]
Phase 2 double-masked trial of VVN539 in subjects with elevated intraocular pressure has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy [Phase 4]
Phase 4 trial comparing preoperative, intraoperative, and topical mitomycin-C use in trabeculectomy for open-angle glaucoma; study terminate…
-
FDA approval · 2023-12-13FDA Approved: IDOSE TR — Original Application (Glaukos Corporation)
The FDA approved IDOSE TR from Glaukos through an original NDA for travoprost delivered intracamerally to treat glaucoma by lowering intraoc…
-
FDA approval · 2023-11-28FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for bimatoprost filed by Alembic Pharmaceuticals Limited.
-
FDA approval · 2023-11-22FDA Approved: BRIMONIDINE TARTRATE — Original Application (Micro Labs Limited)
FDA approves the original application for brimonidine tartrate from Micro Labs Limited, adding a generic ophthalmic product for lowering int…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Phase 3 trial comparing T4032 to Lumigan in ocular hypertension or glaucoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells [Phase 4]
Phase 4 trial evaluating the effect of benzalkonium chloride-preserved vs preservative-free latanoprost eye drops on conjunctival goblet cel…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Anterior-segment OCT (AS-OCT) and Intraoperative OCT (iOCT) for Trans- Conjunctival Needle Revision (TCNR) [NA]
A terminated clinical trial evaluating anterior-segment and intraoperative OCT use during trans-conjunctival needle revision for glaucoma pa…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Tonometry Precision and Accuracy During PROSE Scleral Lens Wear: A Pilot Study [NA]
A completed pilot clinical trial evaluating tonometry precision and accuracy during PROSE scleral lens wear.